Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Entrada Therapeutics, Inc. | 2,495,385 | reported | 02 Nov 2021 | tx 4+2,813,525−2,813,525 |
| BIOVERIS CORP | 1,000 | reported | 26 Jun 2007 | tx 2+2,000 |
| AILERON THERAPEUTICS INC | 0 | reported | 05 Jul 2017 | tx 6+698,493−5,754,448 |
1 purchase reported after at least 12 months of silence — most recent on 05 Jul 2017.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Nov 2021 | CONVERSION | Entrada Therapeutics, Inc. | 2,495,385 | — | |
| 02 Nov 2021 | CONVERSION | Entrada Therapeutics, Inc. | 318,140 | — | |
| 02 Nov 2021 | CONVERSION | Entrada Therapeutics, Inc. | 318,140 | 0.00 USD | deriv |
| 02 Nov 2021 | CONVERSION | Entrada Therapeutics, Inc. | 2,495,385 | 0.00 USD | deriv |
| 05 Jul 2017 | CONVERSION | AILERON THERAPEUTICS INC | 579,093 | — | |
| 05 Jul 2017 | PURCHASE | AILERON THERAPEUTICS INC | 119,400 | 15.00 USD | first after silence |
| 05 Jul 2017 | CONVERSION | AILERON THERAPEUTICS INC | 735,775 | 0.00 USD | deriv |
| 05 Jul 2017 | CONVERSION | AILERON THERAPEUTICS INC | 989,594 | 0.00 USD | deriv |
| 05 Jul 2017 | CONVERSION | AILERON THERAPEUTICS INC | 638,194 | 0.00 USD | deriv |
| 05 Jul 2017 | CONVERSION | AILERON THERAPEUTICS INC | 3,390,885 | 0.00 USD | deriv |
| 26 Jun 2007 | PURCHASE | BIOVERIS CORP | 1,000 | — | |
| 26 Jun 2007 | PURCHASE | BIOVERIS CORP | 1,000 | 21.50 USD |